Chad Strange, Girish S Shroff, Mylene T Truong, Eric M Rohren
Seminars in ultrasound, CT, and MR 2021 DecWhole body positron emission tomography (PET)/computed tomography (CT) imaging with [18F]-fluoro-2-deoxy-D-glucose (FDG) is widely used in oncologic imaging. In the chest, common PET/CT applications include the evaluation of solitary pulmonary nodules, cancer staging, assessment of response to therapy, and detection of residual or recurrent disease. Knowledge of the technical artifacts and potential pitfalls that radiologists may encounter in the interpretation of PET/CT in the thorax is important to avoid misinterpretation and optimize patient management. This article will review pitfalls in the interpretation of PET/CT in the chest related to technical factors, physiologic uptake, false positive findings, false negative findings, and iatrogenic conditions. Copyright © 2021 Elsevier Inc. All rights reserved.
Chad Strange, Girish S Shroff, Mylene T Truong, Eric M Rohren. Pitfalls in Interpretation of PET/CT in the Chest. Seminars in ultrasound, CT, and MR. 2021 Dec;42(6):588-598
PMID: 34895614
View Full Text